[DOI] [PubMed] [Google Scholar] [99].Intarcia Therapeutics Inc, Intarcia Announces FDA Filing Acceptance of New Drug Application (NDA) for ITCA 650 for the Treatment of Type 2 Diabetes, 2017
doi: 10.3389/fcimb.2021.609722 559 LamminpINiccolaiEAmedeiA
Clinical trials show that about 85 to 90 percent of participants lose at least 5 percent of their body weight, which is considered clinically significant weight loss
Symptoms of EPI include abdominal pain, gas and bloating, diarrhea, stomach pain, and steatorrhea (fatty, foul-smelling stool), which can overlap with food reaction symptoms and may occur concomitantly
Individual circumstances and goals determine the appropriate approach
How Peptides Improve Energy: Increase growth hormone production , leading to enhanced energy levels